BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Novus Scientific's TIGR(R) Matrix Surgical Mesh - Exhibited Ahead of Anticipated CE Mark Approval at European Hernia Society 2011, Ghent, Belgium


5/11/2011 9:00:21 AM

SINGAPORE, May 10, 2011 /PRNewswire/ -- Novus Scientific Pte. Ltd today announced that it will be exhibiting at EHS 2011 in Ghent, Belgium ahead of receiving its anticipated CE Mark approval this year for TIGR® MatrixSurgical Mesh, the World's 1st Long-Term Resorbable Synthetic Mesh.

To mark the occasion, a special presentation has been organized on Wednesday May 11th 2011 at the Zebrastraat venue in Ghent (http://www.novusscientific.com/events/), featuring renowned surgeons; Dr. Frederik Berrevoet, Ghent University Hospital, who will lecture on "From polypropylene to TIGR® Matrix: towards the 'ideal' mesh" and Dr. Bruce Ramshaw, Halifax Health Medical Center, Daytona, FL, who will lecture on "Permanent mesh complications: How TIGR® Matrix can help". Henrik Magnusson, co-inventor of TIGR® Matrix will deliver a lecture on the design and properties of long-term resorbable synthetic mesh and answer questions from the audience on how this new class of 100% resorbable synthetic mesh is filling an important gap between biologics and permanent synthetics.

"EHS 2011 marks an important milestone for TIGR® Matrix and for Novus Scientific with presentation of the preliminary one year data from the First in Man clinical study. In this past year we have seen the growing acceptance by many surgeons of TIGR® Matrix as a new approach to soft tissue repair. With the anticipated approval of the CE Mark, we are excited to be able to offer TIGR® Matrix to leading surgeons and hospitals across Europe in the not too distant future,"said Thomas Engstrom, CEO & President of Novus Scientific.

"We look forward to establishing a presence in Europe and to introducing TIGR® Matrix to the leading hernia centers once we attain the anticipated CE Mark. We have a major multicenter randomized controlled study planned with key opinion leaders and are very encouraged by the amount of attention TIGR® Matrix is receiving,"said Tom Haeleydt, responsible for Sales & Marketing EMEA.

TIGR® Matrix is the World's 1st Long-Term Resorbable Synthetic Mesh. US FDA cleared TIGR® MatrixSurgical Mesh for use in reinforcement of soft tissues where weakness exists in February 2010.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices. Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden. The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR® MatrixSurgical Mesh throughout the United States, Canada, and Latin America.

TIGR® is a trademark of Novus Scientific Pte. Ltd

CONTACT:

Mark Hawthorne: +44 7748 988705 - mark.hawthorne@novusscientific.com


James Archetto: +1-781-577-2599 - jim.archetto@novusscientific.com, both of Novus Scientific



SOURCE Novus Scientific Pte. Ltd



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->